Background: Although a majority of studies in cancer biomarker discovery claim to use proportional hazards regression (PHREG) to the study the ability of a biomarker to predict survival, few studies use the predicted probabilities obtained from the model to test the quality of the model. In this paper, we compared the quality of predictions by a PHREG model to that of a linear discriminant analysis (LDA) in both training and test set settings. Methods: The PHREG and LDA models were built on a 491 colorectal cancer (CRC) patient dataset comprised of demo-graphic and clinicopathologic variables, and phenotypic expression of p53 and Bcl-2. Two variable selection methods, stepwise discriminant analysis and the backward selection, were used to i...
Abstract Background: Colorectal cancer is the most common gastrointestinal cancer. Investigating th...
Background: Several models have recently been developed to predict mismatch repair (MMR) gene mutati...
Colorectal cancer is the second leading cause of cancer-related death in Europe and the United State...
Aim: The aim of this study is to determine the factors influencing predicted survival time for patie...
<div><h3>Objective</h3><p>Over the past decades, many studies have used data mining technology to pr...
OBJECTIVE: Over the past decades, many studies have used data mining technology to predict the 5-yea...
Background: Recent guidelines recommend the Lynch Syndrome prediction models MMRPredict, MMRPro, and...
Objective: Over the past decades, many studies have used data mining technology to predict the 5-yea...
Background and Objective: Colorectal cancer (CRC) is one of the most prevalent malignancies in the w...
Over the past decades, many studies have used data mining technology to predict the 5-year survival ...
Earlier detection of colorectal cancer greatly improves prognosis, largely through surgical excision...
Background & Objective: Colorectal cancer (CRC) is one of the most prevalent malignancies in the wor...
OBJECTIVE: To systematically identify and validate published colorectal cancer risk prediction model...
OBJECTIVE: To systematically identify and validate published colorectal cancer risk prediction model...
Objective - To systematically identify and validate published colorectal cancer risk prediction mode...
Abstract Background: Colorectal cancer is the most common gastrointestinal cancer. Investigating th...
Background: Several models have recently been developed to predict mismatch repair (MMR) gene mutati...
Colorectal cancer is the second leading cause of cancer-related death in Europe and the United State...
Aim: The aim of this study is to determine the factors influencing predicted survival time for patie...
<div><h3>Objective</h3><p>Over the past decades, many studies have used data mining technology to pr...
OBJECTIVE: Over the past decades, many studies have used data mining technology to predict the 5-yea...
Background: Recent guidelines recommend the Lynch Syndrome prediction models MMRPredict, MMRPro, and...
Objective: Over the past decades, many studies have used data mining technology to predict the 5-yea...
Background and Objective: Colorectal cancer (CRC) is one of the most prevalent malignancies in the w...
Over the past decades, many studies have used data mining technology to predict the 5-year survival ...
Earlier detection of colorectal cancer greatly improves prognosis, largely through surgical excision...
Background & Objective: Colorectal cancer (CRC) is one of the most prevalent malignancies in the wor...
OBJECTIVE: To systematically identify and validate published colorectal cancer risk prediction model...
OBJECTIVE: To systematically identify and validate published colorectal cancer risk prediction model...
Objective - To systematically identify and validate published colorectal cancer risk prediction mode...
Abstract Background: Colorectal cancer is the most common gastrointestinal cancer. Investigating th...
Background: Several models have recently been developed to predict mismatch repair (MMR) gene mutati...
Colorectal cancer is the second leading cause of cancer-related death in Europe and the United State...